New trends on obesity and NAFLD in Asia

JG Fan, SU Kim, VWS Wong - Journal of hepatology, 2017 - Elsevier
Traditionally, obesity and its related diseases have been considered a problem in Western
countries. However, in the past two decades, urbanisation in many Asian countries has led …

Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta‐analysis

X Mao, KS Cheung, C Peng, LY Mak, HM Cheng… - Hepatology, 2023 - journals.lww.com
Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearan... : Hepatology Steatosis,
HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis …

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

M Eslam, SK Sarin, VWS Wong, JG Fan… - Hepatology …, 2020 - Springer
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

[PDF][PDF] Nonalcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B

HSJ Choi, WP Brouwer, WMR Zanjir, RA de Man… - …, 2020 - Wiley Online Library
Background and Aims Chronic hepatitis B (CHB) and nonalcoholic fatty liver disease are
increasingly observed together in clinical practice, and development of nonalcoholic …

[HTML][HTML] Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

YJ Wong, VH Nguyen, HI Yang, J Li… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Methods We searched 4 databases from inception to December 2021 and pooled study-
level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …

[HTML][HTML] Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

SC Huang, CJ Liu - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has
increased among the general population and chronic hepatitis B (CHB) patients worldwide …

Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B

J Li, HI Yang, ML Yeh, MH Le, AK Le… - The Journal of …, 2021 - academic.oup.com
Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …

Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B

QI Zheng, B Zou, Y Wu, Y Yeo, H Wu… - Alimentary …, 2021 - Wiley Online Library
Background As the prevalence of hepatitis steatosis (HS) increases, the prevalence of HS
among those with chronic hepatitis B (CHB) may also be increasing but data on the effect of …

Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia

M Yang, L Wei - Liver International, 2022 - Wiley Online Library
Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major
causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular …

Hepatocellular carcinoma and non-alcoholic fatty liver disease

P Golabi, L Rhea, L Henry, ZM Younossi - Hepatology international, 2019 - Springer
Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder
worldwide, affecting 25.2% of the general population. In fact, NAFLD is among the most …